Follow us
EN
EN

One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news

Archive

✕
13 October 2021
3515
Life4me + launches new #RespectMyHIV campaign

Life4me + launches new #RespectMyHIV campaign

On October 13th 2021, Life4me + launched their latest awareness campaign, ‘Respect My HIV’. The campaign aims to raise awareness about HIV and to help build a more positive attitude towards all people who differ from the “norm” in some way, whether that be based on HIV ...
6 September 2021
3261
Chinese scientists have identified a promising new antibody for HIV treatment and prevention

Chinese scientists have identified a promising new antibody for HIV treatment and prevention

A group of researchers from the University of Hong Kong have discovered a “powerful antibody” against HIV. BilA-SG, a tandem bi-specific broadly neutralising antibody (bnAb), has been developed and has undergone animal testing where it was shown to be effective in both preventing ...
6 September 2021
2881
Dolutegravir and Darunavir combined with NRTIs are equally effective in treating HIV

Dolutegravir and Darunavir combined with NRTIs are equally effective in treating HIV

According to a study published in the New England Journal of Medicine, dolutegravir and darunavir were equally effective in treating HIV - including in patients with high resistance - when combined with NRTIs. Additionally, trials have shown that tenofovir is non-inferior ...
6 September 2021
3032
Johnson & Johnson’s HIV vaccine trial delivers disappointing results

Johnson & Johnson’s HIV vaccine trial delivers disappointing results

Last week, Johnson & Johnson announced that the HIV vaccine trial known as Imbokodo (HVTN705/HPX2008) failed to significantly reduce the risk of acquiring HIV in over 2,600 women across five sub-Saharan African countries. The initial data showed a 25% efficacy estimate, ...
27 August 2021
2893
Christine Kalatma: The future of HIV treatment

Christine Kalatma: The future of HIV treatment

What will HIV treatment look like in the near future? What developments are underway, and why is there still no HIV vaccine? The Medical Bulletin discussed these and other important issues with Professor Christine Kalatma of the University of the Sorbonne.
26 August 2021
2842
Dolutegravir containing regimens can suppress HIV even with less than ideal adherence

Dolutegravir containing regimens can suppress HIV even with less than ideal adherence

Researchers have found that antiretroviral therapy (ART) regiments based on the the integrase inhibitor, dolutegravir (DTG) are more likely to lead to sustained viral suppression even in the face of poor adherence and treatment interruptions - compared to earlier drugs. ...
23 August 2021
3554
Changes to CDC HIV manual leave U=U activists and advocates frustrated

Changes to CDC HIV manual leave U=U activists and advocates frustrated

Earlier this month Life4me+ reported that the U.S. Centers for Disease Control and Prevention (CDC) had updated their "Guide to the Treatment of Sexually Transmitted Infections". Major changes were made to the HIV transmission section, namely, that a person living with HIV ...
17 August 2021
2844
UNAIDS: Chile finally declares the forced sterilisation of women with HIV illegal

UNAIDS: Chile finally declares the forced sterilisation of women with HIV illegal

According to information published on the UNAIDS website, the Republic of Chile, after many years of debate and court proceedings, has that it was illegal to forcibly sterilise a woman who was living with HIV almost 20 years ago. The government has agreed to a settlement ...
17 August 2021
2588
Could a new technology help us reduce HIV reservoirs in the brain?

Could a new technology help us reduce HIV reservoirs in the brain?

American scientists have developed a technology that can deliver drugs in the form of nanoparticles and potentially reduce HIV reservoirs in the brain that may provoke neurological disorders. Biochemists at the University of Miami believe that the ability of nanoparticles ...
17 August 2021
2631
Analysis of 40 studies of impact of HIV on suicide show conflicting results

Analysis of 40 studies of impact of HIV on suicide show conflicting results

There are many different opinions about whether HIV is related to suicide rates. But there's no unequivocal answer to this question. The Aidsmap information resource (an online magazine that works in the field of HIV and publishes and analyses research related to HIV/AIDS) ...
We use cookies on this site to enhance your experience.
By clicking any button on this website you are giving your consent for us to set cookies.